PE firms queue up for Novartis' Indian arm
NEW DELHI: Private equity firms ChrysCapital, Apollo Global Management, Kedaara Capital and Multiples Equity are evaluating the acquisition of Novartis AG's 70.68% stake in its India-listed arm, according to the people with knowledge of the matter. …